FDA grants Precigen platform technology designation for AdenoVerse
Go back to FDA grants Precigen platform technology designation for AdenoVerse| (NASDAQ: PGEN) | Delayed: 6.60 -0.23 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.83 | 52 Week High | $ | |||
| Open | $6.79 | 52 Week Low | $ | |||
| Day High | $6.92 | P/E | N/A | |||
| Day Low | $6.57 | EPS | $ | |||
| Volume | 5,969,299 | |||||



